FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028358258> ?p ?o ?g. }

• W2028358258 endingPage "774" @default.
• W2028358258 startingPage "767" @default.
• W2028358258 abstract "Background: The hepatotoxicity of highly active antiretroviral therapy (HAART) could enhance liver fibrosis in HIV/Hepatitis C virus (HCV)-coinfected patients. Moreover, HAART-related immune restoration could lessen HCV-associated liver damage. The data on the effect of protease inhibitors (PI) on liver fibrosis are scant and contradictory. No information is available on the relationship between non-nucleoside analogue therapy and liver fibrosis in co-infected patients. Objective: To investigate the associations between the use of different antiretroviral drugs and the liver fibrosis in patients with HIV and HCV infections. Design: Cross-sectional study. Methods: All HIV/HCV co-infected patients with an available liver biopsy and known or estimated duration of HCV infection seen at a Infectious Diseases Unit were included in the study. The fibrosis stage and the fibrosis progression rate were evaluated. Results: The inclusion criteria were fulfilled by 152 patients. Age at HCV infection < 20 years [adjusted odds ratio (AOR), 0.39; 95% confidence interval (CI), 0.19–0.82], PI-based HAART (AOR, 0.39; 95% CI, 0.19–0.78) and nevirapine-based HAART (AOR, 2.56; 95% CI, 1.02–6.58) were associated with fibrosis stage ≥ F3. The variables associated with fibrosis progression rate > 0.2 units/year were age at HCV infection < 20 years (AOR, 0.23; 95% CI, 0.1–0.52), CD4 cell counts ≤ 250 × 106/l at liver biopsy (AOR, 2.8; 95% CI, 1.1–7.1), PI-based HAART (AOR, 0.39; 95% CI, 0.2–0.8) and nevirapine-based HAART (AOR, 3.82; 95% CI, 1.9–7.6). Conclusions: HAART regimens including nevirapine are associated with faster liver fibrosis progression in HIV-infected patients with chronic hepatitis C. In contrast, patients on PI as the backbone of potent antiretroviral therapy are more likely to show less liver fibrosis." @default.
• W2028358258 created "2016-06-24" @default.
• W2028358258 creator A5008499391 @default.
• W2028358258 creator A5013551077 @default.
• W2028358258 creator A5019072295 @default.
• W2028358258 creator A5030301387 @default.
• W2028358258 creator A5043828184 @default.
• W2028358258 creator A5052644280 @default.
• W2028358258 creator A5064867617 @default.
• W2028358258 creator A5070949389 @default.
• W2028358258 creator A5076984288 @default.
• W2028358258 creator A5078695847 @default.
• W2028358258 date "2004-03-01" @default.
• W2028358258 modified "2023-10-15" @default.
• W2028358258 title "Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C" @default.
• W2028358258 cites W1970135355 @default.
• W2028358258 cites W1986859702 @default.
• W2028358258 cites W1987491896 @default.
• W2028358258 cites W2001973858 @default.
• W2028358258 cites W2013907757 @default.
• W2028358258 cites W2034482023 @default.
• W2028358258 cites W2036313720 @default.
• W2028358258 cites W2044996946 @default.
• W2028358258 cites W2045772477 @default.
• W2028358258 cites W2050619287 @default.
• W2028358258 cites W2061968139 @default.
• W2028358258 cites W2064583974 @default.
• W2028358258 cites W2070709974 @default.
• W2028358258 cites W2074424133 @default.
• W2028358258 cites W2085657534 @default.
• W2028358258 cites W2103638317 @default.
• W2028358258 cites W2118108577 @default.
• W2028358258 cites W2119168386 @default.
• W2028358258 cites W2131196141 @default.
• W2028358258 cites W2132290252 @default.
• W2028358258 cites W2155510029 @default.
• W2028358258 cites W2160029914 @default.
• W2028358258 cites W4247791694 @default.
• W2028358258 doi "https://doi.org/10.1097/00002030-200403260-00007" @default.
• W2028358258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15075511" @default.
• W2028358258 hasPublicationYear "2004" @default.
• W2028358258 type Work @default.
• W2028358258 sameAs 2028358258 @default.
• W2028358258 citedByCount "164" @default.
• W2028358258 countsByYear W20283582582012 @default.
• W2028358258 countsByYear W20283582582013 @default.
• W2028358258 countsByYear W20283582582014 @default.
• W2028358258 countsByYear W20283582582015 @default.
• W2028358258 countsByYear W20283582582016 @default.
• W2028358258 countsByYear W20283582582018 @default.
• W2028358258 countsByYear W20283582582021 @default.
• W2028358258 countsByYear W20283582582022 @default.
• W2028358258 countsByYear W20283582582023 @default.
• W2028358258 crossrefType "journal-article" @default.
• W2028358258 hasAuthorship W2028358258A5008499391 @default.
• W2028358258 hasAuthorship W2028358258A5013551077 @default.
• W2028358258 hasAuthorship W2028358258A5019072295 @default.
• W2028358258 hasAuthorship W2028358258A5030301387 @default.
• W2028358258 hasAuthorship W2028358258A5043828184 @default.
• W2028358258 hasAuthorship W2028358258A5052644280 @default.
• W2028358258 hasAuthorship W2028358258A5064867617 @default.
• W2028358258 hasAuthorship W2028358258A5070949389 @default.
• W2028358258 hasAuthorship W2028358258A5076984288 @default.
• W2028358258 hasAuthorship W2028358258A5078695847 @default.
• W2028358258 hasBestOaLocation W20283582581 @default.
• W2028358258 hasConcept C126322002 @default.
• W2028358258 hasConcept C142462285 @default.
• W2028358258 hasConcept C156957248 @default.
• W2028358258 hasConcept C203014093 @default.
• W2028358258 hasConcept C2522874641 @default.
• W2028358258 hasConcept C2775934546 @default.
• W2028358258 hasConcept C2776408679 @default.
• W2028358258 hasConcept C2776455275 @default.
• W2028358258 hasConcept C2777766500 @default.
• W2028358258 hasConcept C2777813720 @default.
• W2028358258 hasConcept C2779130552 @default.
• W2028358258 hasConcept C2780559512 @default.
• W2028358258 hasConcept C2993143319 @default.
• W2028358258 hasConcept C3013748606 @default.
• W2028358258 hasConcept C71924100 @default.
• W2028358258 hasConcept C90924648 @default.
• W2028358258 hasConceptScore W2028358258C126322002 @default.
• W2028358258 hasConceptScore W2028358258C142462285 @default.
• W2028358258 hasConceptScore W2028358258C156957248 @default.
• W2028358258 hasConceptScore W2028358258C203014093 @default.
• W2028358258 hasConceptScore W2028358258C2522874641 @default.
• W2028358258 hasConceptScore W2028358258C2775934546 @default.
• W2028358258 hasConceptScore W2028358258C2776408679 @default.
• W2028358258 hasConceptScore W2028358258C2776455275 @default.
• W2028358258 hasConceptScore W2028358258C2777766500 @default.
• W2028358258 hasConceptScore W2028358258C2777813720 @default.
• W2028358258 hasConceptScore W2028358258C2779130552 @default.
• W2028358258 hasConceptScore W2028358258C2780559512 @default.
• W2028358258 hasConceptScore W2028358258C2993143319 @default.
• W2028358258 hasConceptScore W2028358258C3013748606 @default.
• W2028358258 hasConceptScore W2028358258C71924100 @default.
• W2028358258 hasConceptScore W2028358258C90924648 @default.
• W2028358258 hasIssue "5" @default.

• next